(2S,3S)-2-((R)-4-(4-(2-Hydroxyethoxy)phenyl)-2,5-dioxo-imidazolidin-1-yl)-3-phenyl-N-(4-propionylthiazol-2-yl)butyramide
CAS: 876755-27-0
Rif. 3D-BKB75527
| 1mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- RO 4927350
- 1-Imidazolidineacetamide, 4-[4-(2-hydroxyethoxy)phenyl]-2,5-dioxo-N-[4-(1-oxopropyl)-2-thiazolyl]-α-[(1S)-1-phenylethyl]-, (αS,4R)-
- (αS,4R)-4-[4-(2-Hydroxyethoxy)phenyl]-2,5-dioxo-N-[4-(1-oxopropyl)-2-thiazolyl]-α-[(1S)-1-phenylethyl]-1-imidazolidineacetamide
- Ro 4927350
- (2S,3S)-2-[(4R)-4-[4-(2-Hydroxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-N-(4-propionylthiazol-2-yl)butanamide
(2S,3S)-2-((R)-4-(4-(2-Hydroxyethoxy)phenyl)-2,5-dioxo-imidazolidin-1-yl)-3-phenyl-N-(4-propionylthiazol-2-yl)butyramide is an aromatic ketone that has been shown to inhibit mitogen activated protein kinase (MAPK) and mitogen activated protein kinases (MAPKs). It is a potent inhibitor of the MAPK signaling pathway. This drug binds to the ATP binding site on MAPK and blocks the exchange of ATP for MgATP, which prevents the phosphorylation of tyrosine residues on MAPK. The carboxy group in this compound reacts with the primary amino group on MAPK to form a condensation product. This reaction inhibits protein synthesis by blocking the activation of ribosomes by tRNA.
Proprietà chimiche
Richiesta tecnica su: 3D-BKB75527 (2S,3S)-2-((R)-4-(4-(2-Hydroxyethoxy)phenyl)-2,5-dioxo-imidazolidin-1-yl)-3-phenyl-N-(4-propionylthiazol-2-yl)butyramide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
